Cleared Traditional

K252749 - Medconn 8K Glycated Hemoglobin Test System (FDA 510(k) Clearance)

Jan 2026
Decision
130d
Days
Class 2
Risk

K252749 is an FDA 510(k) clearance for the Medconn 8K Glycated Hemoglobin Test System. This device is classified as a Hemoglobin A1c Test System (Class II - Special Controls, product code PDJ).

Submitted by Shanghai Medconn Medical Technology Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on January 6, 2026, 130 days after receiving the submission on August 29, 2025.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1373. Quantitative Determination Of Hemoglobin A1c To Aid In The Diagnosis Of Diabetes..

Submission Details

510(k) Number K252749 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2025
Decision Date January 06, 2026
Days to Decision 130 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code PDJ - Hemoglobin A1c Test System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1373
Definition Quantitative Determination Of Hemoglobin A1c To Aid In The Diagnosis Of Diabetes.